Seelos Therapeutics Inc (SEELQ)

[hentied]

Not sure about your calculation, maybe I am misunderstanding?

APRI has expenses of about $30 mill per year. I doubt that changes once Vitaros starts generating revenues. Maybe those expenses even go higher. $35 mill - $30 mill = $5 mill. earnings (or about 15 cents per share).

I assume we are speaking about the royalties after all licensing has been completed?